CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 115 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $37,000 | +5.7% | 20,054 | +53.1% | 0.00% | 0.0% |
| Q1 2022 | $35,000 | -63.5% | 13,101 | -13.7% | 0.00% | -66.7% |
| Q2 2021 | $96,000 | -87.0% | 15,182 | -84.1% | 0.00% | -89.3% |
| Q1 2021 | $737,000 | +504.1% | 95,284 | +552.9% | 0.03% | +250.0% |
| Q2 2020 | $122,000 | +14.0% | 14,595 | +5.0% | 0.01% | -11.1% |
| Q1 2020 | $107,000 | -29.1% | 13,900 | +39.0% | 0.01% | -59.1% |
| Q4 2018 | $151,000 | – | 10,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,803,700 | $25,130,000 | 0.91% |
| Altium Capital Management LP | 663,800 | $2,874,000 | 0.79% |
| Rubric Capital Management LP | 2,406,449 | $10,420,000 | 0.49% |
| RTW INVESTMENTS, LP | 6,029,700 | $26,109,000 | 0.38% |
| Orbimed Advisors | 3,214,509 | $13,919,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 152,345 | $660,000 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 980,085 | $4,244,000 | 0.12% |
| Point72 Asset Management, L.P. | 6,303,025 | $27,292,000 | 0.11% |
| Sender Co & Partners, Inc. | 40,720 | $176,000 | 0.09% |
| Manteio Capital LLC | 15,067 | $65,000 | 0.08% |